https://doi.org/10.1016/s0140-6736(21)00432-3
J
Justin Taylor
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
271
Papers
12.6K
Citations
36
h-index
71
i10-index
Justin Taylor is an academic researcher from AstraZeneca (United Kingdom). The author has contributed to research in topics: Acute Myeloid Leukemia Research & Chronic Lymphocytic Leukemia Research & Nuclear Structure and Function. The author has an h-index of 36, co-authored 231 publications.
ORCID: 0000-0003-4407-6325Papers by this author
worksSingle-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials
2021 · The Lancet · 1,200 citations
Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group.
1996 · PubMed · 759 citations
Phase I First-in-Human Dose Escalation Study of the oral SF3B1 modulator H3B-8800 in myeloid neoplasms
2021 · Leukemia · 172 citations
https://doi.org/10.1038/s41375-021-01328-9
Kinase-impaired BTK mutations are susceptible to clinical-stage BTK and IKZF1/3 degrader NX-2127
2024 · Science · 136 citations
https://doi.org/10.1126/science.adi5798
Germ cell tumors and associated hematologic malignancies evolve from a common shared precursor
2020 · Journal of Clinical Investigation · 51 citations
https://doi.org/10.1172/jci139682
Targeted Therapy Development in Acute Myeloid Leukemia
2023 · Biomedicines · 46 citations
https://doi.org/10.3390/biomedicines11020641
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat